Candriam SCA’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-67,551
| Closed | -$8.89M | – | 833 |
|
|
2020
Q4 | $8.89M | Sell |
67,551
-118,170
| -64% | -$15.5M | 0.07% | 283 |
|
|
2020
Q3 | $9.38M | Hold |
185,721
| – | – | 0.09% | 248 |
|
|
2020
Q2 | $8.85M | Buy |
185,721
+13,966
| +8% | +$666K | 0.09% | 233 |
|
|
2020
Q1 | $9.64M | Hold |
171,755
| – | – | 0.11% | 219 |
|
|
2019
Q4 | $9.86M | Sell |
171,755
-47,245
| -22% | -$2.71M | 0.11% | 221 |
|
|
2019
Q3 | $7.88M | Sell |
219,000
-104,000
| -32% | -$3.74M | 0.1% | 229 |
|
|
2019
Q2 | $10M | Sell |
323,000
-102,000
| -24% | -$3.16M | 0.12% | 189 |
|
|
2019
Q1 | $9.97M | Buy |
425,000
+280,000
| +193% | +$6.57M | 0.13% | 189 |
|
|
2018
Q4 | $2M | Buy |
+145,000
| New | +$2M | 0.03% | 464 |
|